Shirazi 2012.

Trial name or title	A placebo‐controlled clinical trial to assess efficacy of tranexamic acid in reducing haemorrhage after vaginal delivery.
Methods	Randomised, not blinded, assignment ‐ parallel.
Participants	Women with term, singleton pregnancy candidate for the first vaginal delivery. Exclusion criteria ‐ severe medical complications involving the heart, brain, kidney; allergy to tranexamic acid; visual problems; severe pregnancy complications such as pre‐eclampsia; thromboembolic events; placenta abruption.
Interventions	Intervention group ‐ 1 g tranexamic acid in 20 mL 5% dextrose IV soon after neonatal delivery. Control group ‐ 20 mL 5% dextrose with 10 mL normal saline IV soon after neonatal delivery.
Outcomes	Primary outcomes ‐ haemoglobin before and after delivery, need for transfusion, surgery, hysterectomy, death, thrombotic events.
Starting date	10 OCT 2012.
Contact information	Dr Fereshteh Heidari Shirazi. Shahid Beheshti Hospital 5th km of Ghotberavandi blvd. Kashan Iran Kashan Isfahan ISLAMIC REPUBLIC OF IRAN 87159/88141 hamiidi@yahoo.com
Notes

CS: caesarean section
 IV: intravenously
 PPH: postpartum haemorrhage